Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up

Calcineurin inhibitor (CNI) toxicity contributes to chronic allograft nephropathy (CAN). In the 2-year, randomized, study, we showed that 50% cyclosporin (CsA) reduction in combination with mycophenolate mofetil (MMF) treatment improves kidney function without increasing the risk for graft rejection...

Descripción completa

Detalles Bibliográficos
Autores principales: Frimat, L., Cassuto-Viguier, E., Provôt, F., Rostaing, L., Charpentier, B., Akposso, K., Moal, M. C., Lang, P., Glotz, D., Caillard, S., Ducloux, D., Pouteil-Noble, C., Girardot-Seguin, S., Kessler, M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913628/
https://www.ncbi.nlm.nih.gov/pubmed/20706667
http://dx.doi.org/10.1155/2010/402750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913628/
https://www.ncbi.nlm.nih.gov/pubmed/20706667
http://dx.doi.org/10.1155/2010/402750

Ejemplares similares